Document reference

2022/2819(DEA)  
Labelling requirements for unauthorised investigational and unauthorised auxiliary medicinal products for human use  
Basic information  

2022/2819(DEA)

DEA - Delegated acts procedure

Supplementing 2012/0192(COD)

Subject
4.20.02 Medical research
4.20.02.06 Clinical practice and experiments
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
06/09/2022
Non-legislative basic document published
C(2022)06240
06/09/2022
Initial period for examining delegated act 2 month(s)
14/09/2022
Committee referral announced in Parliament
15/11/2022
Delegated act not objected by Parliament
Technical information  
Procedure reference
2022/2819(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/9/10019
Documentation gateway